{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:26:32Z","timestamp":1787160392159,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10620-011-1728-5","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T08:33:55Z","timestamp":1305016435000},"page":"2067-2072","source":"Crossref","is-referenced-by-count":79,"title":["Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects"],"prefix":"10.1007","volume":"56","author":[{"given":"Mark","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Weitsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meridythe M.","family":"Amichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Pokkunuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"1728_CR1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0399-8320(04)95011-7","volume":"28","author":"G Bommelaer","year":"2004","unstructured":"Bommelaer G, Poynard T, Le Pen C, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol. 2004;28:554\u2013561.","journal-title":"Gastroenterol Clin Biol"},{"key":"1728_CR2","first-page":"S3","volume":"3","author":"HB El-Serag","year":"2003","unstructured":"El-Serag HB. Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life. Rev Gastroenterol Disord. 2003;3:S3\u2013S11.","journal-title":"Rev Gastroenterol Disord"},{"key":"1728_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L Agreus","year":"1995","unstructured":"Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671\u2013680.","journal-title":"Gastroenterology"},{"key":"1728_CR4","unstructured":"Pyleris E, Bourboulis EG, Koussoulas B, Barbatzas C. Prevalence of small intestinal bacterial overgrowth in a greek cohort: relationship with irritable bowel syndrome. Presented at the 18th United European gastroenterology week. Barcelona, Spain, 2010."},{"key":"1728_CR5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10620-006-9104-6","volume":"51","author":"M Pimentel","year":"2006","unstructured":"Pimentel M, Chatterjee S, Chow EJ, Park S, Kong Y. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci. 2006;51:1297\u20131301.","journal-title":"Dig Dis Sci"},{"key":"1728_CR6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","volume":"101","author":"AI Sharara","year":"2006","unstructured":"Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101:326\u2013333.","journal-title":"Am J Gastroenterol"},{"key":"1728_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","volume":"145","author":"M Pimentel","year":"2006","unstructured":"Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557\u2013563.","journal-title":"Ann Intern Med"},{"key":"1728_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22\u201332.","journal-title":"N Engl J Med"},{"key":"1728_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14787210.3.2.201","volume":"3","author":"L Gerard","year":"2005","unstructured":"Gerard L, Garey KW, DuPont HL. Rifaximin: A nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Therapy. 2005;3:201\u2013211.","journal-title":"Expert Rev Anti Infect Therapy"},{"key":"1728_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","volume":"51","author":"ZD Jiang","year":"2005","unstructured":"Jiang ZD, DuPont HL. Rifaximin: in vitro and in vivo antibacterial activity\u2014a review. Chemotherapy. 2005;51:67\u201372.","journal-title":"Chemotherapy"},{"key":"1728_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1179\/joc.2008.20.2.186","volume":"20","author":"EA Debbia","year":"2008","unstructured":"Debbia EA, Maioli E, Roveta S, Marchese A. Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations. J Chemother. 2008;20:186\u2013194.","journal-title":"J Chemother"},{"key":"1728_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","volume":"53","author":"J Yang","year":"2008","unstructured":"Yang J, Lee HR, Low K, Chatterjee S, Pimentel M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci. 2008;53:169\u2013174.","journal-title":"Dig Dis Sci"},{"key":"1728_CR13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","volume":"7","author":"AC Ford","year":"2009","unstructured":"Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279\u20131286.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1728_CR14","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s10620-010-1276-4","volume":"55","author":"ED Shah","year":"2010","unstructured":"Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci. 2010;55:2441\u20132449.","journal-title":"Dig Dis Sci"},{"key":"1728_CR15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","volume":"56","author":"I Posserud","year":"2007","unstructured":"Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802\u2013808.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1728-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1728-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:44:50Z","timestamp":1559231090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1728-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1728-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]}}}